Get the Stockscreener App
11.96
2.57%
0.30
After Hours:
12.03
0.07
+0.59%
Optimizerx Corp stock is traded at $11.96, with a volume of 326.14K.
It is up +2.57% in the last 24 hours and down -10.01% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$11.66
Open:
$11.81
24h Volume:
326.14K
Relative Volume:
1.25
Market Cap:
$222.94M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-14.95
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
-5.08%
1M Performance:
-10.01%
6M Performance:
-10.08%
1Y Performance:
+120.26%
1-Day Range:
$11.70
$12.34
1-Week Range:
$11.44
$12.60
52-Week Range:
$3.9914
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
11.96 | 217.35M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Market Outlook: Will OptimizeRx Corporation benefit from sector rotation2025 Risk Factors & AI Powered Trade Plan Recommendations - baoquankhu1.vn
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Is OptimizeRx Corporation stock attractive after correctionSell Signal & Daily Profit Maximizing Trade Tips - Улправда
OptimizeRx (OPRX): Clinical Network Growth Drives 37% Reach Boost Amid Analyst Upgrades - Finviz
9 Best Performing Micro Cap Stocks in 2025 - Insider Monkey
OptimizeRx and Experian collaborate to improve privacy-safe identity resolution in healthcare marketing - MarketScreener
OptimizeRx Corp. and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing - marketscreener.com
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing - The Manila Times
New data tie-up aims to make consumer health ads more precise and private - Stock Titan
Best Growth Stocks to Buy for July 22nd - MSN
Head to Head Comparison: Manhattan Associates (NASDAQ:MANH) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx (NASDAQ:OPRX) Insider Sells $18,751.88 in Stock - MarketBeat
OptimizeRx CFO sells $18,751 in shares By Investing.com - Investing.com Nigeria
OptimizeRx CFO sells $18,751 in shares - Investing.com
OptimizeRx Corp Executive Sells Shares - TradingView — Track All Markets
How OptimizeRx Corporation stock responds to policy changesMarket Rally & Stepwise Trade Signal Implementation - Улправда
Is OptimizeRx Corporation stock oversold or undervaluedRecession Risk & AI Forecast for Swing Trade Picks - Улправда
Is OptimizeRx Corporation stock a good choice for value investors2025 EndofYear Setup & High Accuracy Investment Signals - DonanımHaber
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
OptimizeRx (NASDAQ:OPRX) Cut to “Hold” at Zacks Research - Defense World
OptimizeRx (NASDAQ:OPRX) Cut to "Hold" at Zacks Research - MarketBeat
OPRX FinancialsIncome Statement - Quiver Quantitative
OptimizeRx Corp. Expands Point-of-Care Network with Four New Partner Agreements - Quiver Quantitative
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network - The Manila Times
Officer D'Silva Surrenders 868 Of OptimizeRx Corp [OPRX] - TradingView — Track All Markets
OptimizeRx Corp (OPRX) insider has 868 shares withheld for taxes - Stock Titan
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to “Strong-Buy” - Defense World
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to "Strong-Buy" - MarketBeat
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Cut to "Buy" at Wall Street Zen - MarketBeat
OptimizeRx (NASDAQ:OPRX) Cut to “Buy” at Wall Street Zen - Defense World
OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook - MSN
Financial Comparison: OptimizeRx (NASDAQ:OPRX) and SS&C Technologies (NASDAQ:SSNC) - Defense World
OptimizeRx Corporation (OPRX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How Recent Developments Are Shaping the OptimizeRx Investment Story - Yahoo Finance
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
OptimizeRx Corporation's (NASDAQ:OPRX) 33% Share Price Plunge Could Signal Some Risk - simplywall.st
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX - MarketBeat
Is OptimizeRx Corporation stock attractive for growth ETFs2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX - MarketBeat
Can OptimizeRx Corporation stock deliver surprise earnings beat2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Is a relief rally coming for OptimizeRx Corporation holdersInsider Selling & Fast Gain Swing Alerts - newser.com
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - MSN
Can OptimizeRx Corporation stock sustain market leadershipJuly 2025 Update & Technical Pattern Alert System - newser.com
Automated trading signals detected on OptimizeRx CorporationJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
OptimizeRx CorporationCommon Stock (NQ: OPRX - Markets Financial Content
Stephens Issues Pessimistic Forecast for OptimizeRx (NASDAQ:OPRX) Stock Price - MarketBeat
OptimizeRx : Corporate PresentationNovember 2025 - MarketScreener
How OptimizeRx Corporation stock performs in rate cut cyclesJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):